Third Harmonic Bio, Inc.
THRDDelisted Jul 31, 2025- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001923840
Third Harmonic Bio, Inc. was delisted on Jul 31, 2025; its insiders filed their last Form 4 on Aug 14, 2025; 107 institutions reported holding it in 13F filings for Q2 2025, worth $210.2M in total; no superinvestor held it.
13F holders, Q4 2024
Institutional positions in Third Harmonic Bio, Inc. as of Dec 31, 2024. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
- Institutional holders
- 98
- +13 vs. Q3 2024
- Shares held
- 45.0M
- +923.6K (+2.1%) vs. Q3 2024
- Total value
- $462.5M
- −$134.1M (−22.5%) vs. Q3 2024
- New holders
- 26
- 37 more added
- Sold out
- 13
- 20 more reduced
Compare with Q3 2024: new holders, sold out and not filed yet
Holders and value by quarter
Institutions reporting THRD on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 4 | $110.0K |
| Q1 2026 | 4 | $110.0K |
| Q4 2025 | 4 | $111.5K |
| Q3 2025 | 18 | $1.19M |
| Q2 2025 | 107 | $210.2M |
| Q1 2025 | 100 | $134.4M |
| Q4 2024 | 98 | $462.5M |
| Q3 2024 | 85 | $596.6M |
| Q2 2024 | 77 | $523.2M |
| Q1 2024 | 71 | $357.6M |
| Q4 2023 | 62 | $416.0M |
| Q3 2023 | 56 | $241.5M |
| Q2 2023 | 48 | $173.5M |
| Q1 2023 | 49 | $149.7M |
| Q4 2022 | 50 | $153.1M |
| Q3 2022 | 40 | $672.8M |
| Q2 2022 | 0 | $0 |
| Q1 2022 | 0 | $0 |
| Q4 2021 | 0 | $0 |
| Q3 2021 | 0 | $0 |
| Q2 2021 | 0 | $0 |
| Q1 2021 | 0 | $0 |
Institutions, Q4 2024
Shares, value and share of portfolio for each institution holding Third Harmonic Bio, Inc.; share changes are against Q3 2024.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| Invesco Ltd. | 0 | $0 | 0.00% | −265,134−100.0% | Sold out |
| Woodline Partners LP | 0 | $0 | 0.00% | −123,923−100.0% | Sold out |
| Qube Research & Technologies Ltd | 0 | $0 | 0.00% | −20,125−100.0% | Sold out |
| Franklin Resources Inc | 0 | $0 | 0.00% | −19,516−100.0% | Sold out |
| AQR Capital Management LLC | 0 | $0 | 0.00% | −13,965−100.0% | Sold out |
| HRT Financial LP | 0 | $0 | 0.00% | −11,259−100.0% | Sold out |
| Point72 (DIFC) Ltd | 0 | $0 | 0.00% | −763−100.0% | Sold out |
| Federated Hermes, Inc. | 0 | $0 | 0.00% | −661−100.0% | Sold out |
| Baldwin Brothers Inc | 0 | $0 | 0.00% | −262−100.0% | Sold out |
| Ronald Blue Trust, Inc. | 0 | $0 | 0.00% | −58−100.0% | Sold out |
| Capital Performance Advisors LLP | 0 | $0 | 0.00% | −25−100.0% | Sold out |